RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE
Na minha lista:
CHATURVEDI, S.K., ET AL., RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE. PROGRESS IN PALLIATIVE CARE, Vol. 4, no. 3 (1996), p. 80-84.
Ref.
55108
Localização:
SIIS R.1147
Palabras clave:
Cáncer, Enfermos terminales, Fármacos, Psicótropos, Síntomas, Tratamiento
Cáncer, Enfermos terminales, Fármacos, Psicótropos, Síntomas, Tratamiento
Registos relacionados: RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE
- PSYCHOTROPIC MEDICATION HISTORY OF INPATIENT ADOLESCENTS. IS THERE A RATIONALE FOR BENZODIAZEPINE PRESCRIPTION?
- PSYCHOTROPIC MEDICATION FOR ADHD
- GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
- A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS
- STATEWIDE LONGITUDINAL SURVEY OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH MENTAL RETARDATION: 1994 TO 200